Mechanical properties,biological behaviour and drug release capability of nano TiO 2 -HAp-Alginate composite scaffolds for potential application as bone implant material
Restricted accessResearch articleFirst published online September, 2016
Mechanical properties,biological behaviour and drug release capability of nano TiO 2 -HAp-Alginate composite scaffolds for potential application as bone implant material
Nanocomposite scaffolds of TiO2 and hydroxyapatite nanoparticles with alginate as the binding agent were fabricated using the freeze drying technique. TiO2, hydroxyapatite and alginate were used in the ratio of 1:1:4. The scaffolds were characterized using X-ray diffraction, fourier transform infrared spectroscopy, and scanning electron microscopy. The biocompatibility of the scaffolds was evaluated using cell adhesion and MTT assay on osteosarcoma (MG-63) cells. Scanning electron microscopy analysis revealed that cells adhered to the surface of the scaffolds with good spreading. The mechanical properties of the scaffolds were investigated using dynamic mechanical analysis. The swelling ability, porosity, in vitro degradation, and biomineralization of the scaffolds were also evaluated. The results indicated controlled swelling, limited degradation, and enhanced biomineralization. Further, drug delivery studies of the scaffolds using the chemotherapeutic drug methotrexate exhibited an ideal drug release profile. These scaffolds are proposed as potential candidates for bone tissue engineering and drug delivery applications.
BuckwalterJAGlimcherMJCooperRR. Bone biology. I. Structure, blood supply, cells, matrix, and mineralization. Instr Course Lect1996; 45: 371–386.
2.
BuckwalterJAGlimcherMJCooperRR. Bone biology. II. Formation, form, modeling, remodeling, and regulation of cell function. Instr Course Lect1996; 45: 387–399.
3.
PorterJRRuckhTTPopatKC. Bone tissue engineering: a review in bone biomimetics and drug delivery strategies. Biotechnol Prog2009; 25: 1539–1560.
4.
KretlowJDMikosAG. Review: mineralization of synthetic polymer scaffolds for bone tissue engineering. Tissue Eng2007; 13: 927–938.
AlbrektssonTJohanssonC. Osteoinduction, osteoconduction and osseointegration. Eur Spine J2001; 10: S96–S101.
7.
MistryASMikosAG. Tissue engineering strategies for bone regeneration. Adv Biochem Eng Biotechnol2005; 94: 1–22.
8.
HutmacherDW. Polymeric scaffolds in tissue engineering bone and cartilage. Biomaterials2000; 21: 2529–2543.
9.
ChenGPUshidaTTateishiT. Preparation of poly (L-lactic acid) and poly (DL-lactic-co-glycolic acid) foams by use of ice microparticulates. Biomaterials2001; 18: 2563–2567.
10.
LeeSHShinH. Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering. Adv Drug Deliv Rev2007; 59: 339–359.
11.
Le BolayNSantranVDechambreG. Production, by co-grinding in a media mill, of porous biodegradable polylactic acid-apatite composite materials for bone tissue engineering. Powder Technol2009; 190: 89–94.
12.
FostadGHafellBFørdeA. Loadable TiO2 scaffolds – a correlation study between processing parameters, micro CT analysis and mechanical strength. J Eur Ceram Soc2009; 29: 2773–2781.
13.
NygrenHTengvallPLundstromI. The initial reactions of TiO2 with blood. J Biomed Mater Res1997; 34: 487–492.
14.
RinconJCXiaoYYoungWG. Enhanced proliferation, attachment and osteopontin expression by porcine periodontal cells exposed to Emdogain. Arch Oral Biol2005; 50: 1047–1054.
15.
SabetrasekhRTiainenHReselandJE. Impact of trace elements on biocompatibility of titanium scaffolds. Biomed Mater2010; 5: 15003–15003.
16.
TiainenHLyngstadaasSPEllingsenJE. Ultra-porous titanium oxide scaffold with high compressive strength. J Mater Sci Mater Med2010; 21: 2783–2792.
HaugenHJMonjoMRubertM. Porous ceramic titanium dioxide scaffolds promote bone formation in rabbit peri-implant cortical defect model. Acta Biomater2013; 9: 5390–5399.
19.
KimHWKimHESalihV. Hydroxyapatite and titania sol-gel composite coatings on titanium for hard tissue implants; mechanical and in vitro biological performance. J Biomed Mater Res B Appl Biomater2005; 72: 1–8.
20.
KhalilKAKimSWKimKW. A novel bio-nanocomposites composed of hydroxyapatite reinforced with TiO2 electrospun nanofiber consolidated using high-frequency induction heating. Int J Appl Ceram Technol2011; 8: 523–531.
21.
NathanaelAJArulNSPonpandianN. Nanostructured leaf like hydroxyapatite/TiO2 composite coatings by simple sol–gel method. Thin Solid Films2010; 518: 7333–7338.
22.
SoundrapandianCSaBDattaS. Organic-inorganic composites for bone drug delivery. AAPS PharmSciTech2009; 10: 1158–1171.
23.
MourinoVBoccacciniAR. Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds. J R Soc Interface2010; 7: 209–227.
MeyersMAChenPLinAY. Biological materials: structure and mechanical properties. Prog Mater Sci2008; 53: 1–206.
26.
BoccacciniARMaquetV. Bioresorbable and bioactive polymer/bioglass® composites with tailored pore structure for tissue engineering applications. Comp Sci Technol2003; 63: 2417–2429.
27.
NaikKChatterjeeAPrakashH. Mesoporous TiO2 nanoparticles containing Ag ion with excellent antimicrobial activity at remarkable low silver concentrations. J Biomed Nanotechnol2013; 9: 664–673.
28.
JadalannagariSMoreSKowshikM. Low temperature synthesis of hydroxyapatite nano-rods by a modified sol-gel technique. Mater Sci Eng C Mater Biol Appl2011; 31: 1534–1538.
29.
LiuyunJYubaoLChengdongL. A novel composite membrane of chitosan–carboxymethyl cellulose polyelectrolyte complex membrane filled with nano-hydroxyapatite I. Preparation and properties. J Mater Sci Mater Med2009; 20: 1645–1652.
30.
PeterMBinulalNSNairSV. Novel biodegradable chitosan–gelatin/nano-bioactive glass ceramic composite scaffolds for alveolar bone tissue engineering. Chem Eng J2010; 158: 353–361.
31.
JayasuriyaAC. Acceleration of biomimetic mineralization to apply in bone regeneration. Biomed Mater2008; 3: 015003–015003.
32.
WangLSheltonRMCooperPR. Evaluation of sodium alginate for bone marrow cell tissue engineering. Biomaterials2003; 24: 3475–3481.
33.
BoninoCAKrebsMDSaquingCD. Electrospinning alginate-based nanofibers: from blends to crosslinked low molecular weight alginate-only systems. Carbohydr Polym2011; 85: 111–119.
KazySKSarPSinghSP. Extracellular polysaccharides of a copper-sensitive and a copper-resistant Pseudomonas aeruginosa strain: synthesis, chemical nature and copper binding. World J Microbiol Biotechnol2002; 18: 583–588.
36.
MinS-HJinH-HJunBS. Effect of reaction conditions on pore configuration and mechanical property for porous hydroxyapatite prepared by polymer sponge method. Key Eng Mater2007; 336–338: 1567–1570.
37.
KlawitterJJHulbertSF. Application of porous ceramics for the attachment of load-bearing internal orthopaedic applications. J Biomed Mater Res Symp1971; 5: 161–229.
38.
KarageorgiouVKaplanD. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials2005; 26: 5474–5491.
39.
MooneyDJBaldwinDFSuhNP. Novel approach to fabricate porous sponges of poly (D,L-lactic-co-glycolic acid) without the use of organic solvents. Biomaterials1996; 17: 1417–1422.
40.
CimaLGVacantiJPVacantiC. Tissue engineering by cell transplantation using degradable polymer substrates. J Biomech Eng1991; 113: 143–151.
41.
YangSLeongKFDuZ. The design of scaffolds for use in tissue engineering. Part I. Traditional factors. Tissue Eng2001; 7: 679–689.
42.
KumarPTRamyaCJayakumarR. Drug delivery and tissue engineering applications of biocompatible pectin-chitin/nano CaCO3 composite scaffolds. Colloids Surf B Biointerfaces2013; 106: 109–116.
43.
PeterMKumarSPTBinulalNS. Development of novel α-chitin/nanobioactive glass ceramic composite scaffolds for tissue engineering applications. Carbohydr Polym2009; 78: 926–931.
44.
LuTLiYChenT. Techniques for fabrication and construction of three-dimensional scaffolds for tissue engineering. Int J Nanomedicine2013; 8: 337–350.
45.
NandiSKKunduBDattaS. The repair of segmental bone defects with porous bioglass: an experimental study in goat. Res Vet Sci2009; 86: 162–173.
46.
RománJPadillaSVallet-RegíM. Sol-Gel glasses as precursors of bioactive glass ceramics. Chem Mater2003; 15: 798–806.
KokuboT. Bioactive glass ceramics: properties and applications. Biomaterials1991; 12: 155–163.
49.
KokuboTTakadamaH. How useful is SBF in predicting in vivo bone activity?Biomaterials2006; 27: 2907–2915.
50.
BarrereFBlitterswijkCAGrootK. Influence of ionic strength and carbonate on the Ca-P coating formation from SBF×5 solution. Biomaterials2002; 23: 1921–1930.
51.
BarrereFBlitterswijkCAGrootK. Nucleation of biomimetic Ca-P coatings on Ti6Al4V from a SBF×5 solution: influence of magnesium. Biomaterials2002; 23: 2211–2220.
52.
ChouYFChiouWAXuYH. The effect of pH on the structural evolution of accelerated biomimetic apatite. Biomaterials2004; 25: 5323–5331.
53.
CloverJGowenM. Are MG-63 and HOS TE85 human osteosarcoma cell lines representative models of the osteoblastic phenotype?Bone1994; 15: 585–591.
54.
PriceNBendallSPFrondozaC. Human osteoblast-like cells (MG 63) proliferate on a bioactive glass surface. J Biomed Mater Res A1997; 37: 394–400.
55.
FerryJD. Viscoelastic properties of polymers, 3rd ed. New York: Wiley, 1980.
56.
ManoJFReisRLCunhaAMDynamic mechanical analysis in polymers for medical applications. In: ReisRLCohnD (eds). Polymer based systems on tissue engineering, replacement and regeneration, 1st ed. Netherlands: Kluwer Academic Publishers, 2002, pp. 139–164.
57.
RaiBTeohSHHutmacherDW. Novel PCL-based honeycomb scaffolds as drug delivery systems for rhBMP-2. Biomaterials2005; 26: 3739–3748.
58.
KimHWKnowlesJCKimHE. Development of hydroxyapatite bone scaffold for controlled drug release via poly (e-caprolactone) and hydroxyapatite hybrid coatings. J Biomed Mater Res Part B Appl Biomater2004; 70: 240–249.
59.
KimHWKnowlesJCKimHE. Hydroxyapatite/poly(e-caprolactone) composite coatings on hydroxyapatite porous bone scaffold for drug delivery. Biomaterials2004; 25: 1279–1287.
60.
MurphyWLPetersMCKohnDH. Sustained release of vascular endothelial growth factor from mineralized poly (lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials2000; 21: 2521–2527.
61.
GomesMEReisRL. Biodegradable polymers and composites in biomedical applications from catgut to tissue engineering. Part II. Systems for temporary replacement and advanced tissue regeneration. Int Mater Rev2004; 49: 274–285.
DuarteARManoJFReisRL. Preparation of chitosan scaffolds loaded with dexamethasone for tissue engineering applications using supercritical fluid technology. Eur Polym J2009; 45: 141–148.
64.
BaroliB. From natural bone graft to tissue engineering therapeutics: brainstorming on pharmaceutical formulative requirements and challenges. J Pharm Sci2009; 98: 1317–1375.
65.
SartoriTMurakamiFSCruzAP. Development and validation of a fast RP-HPLC method for determination of methotrexate entrapment efficiency in polymeric nanocapsules. J Chromatogr Sci2008; 46: 505–509.
66.
HitchingsGHSmithSL. Dihydrofolate reductases as targets for inhibitors. Adv Enzyme Regul1980; 18: 349–371.
67.
CalabresiP. The pharmacological basis of therapeutics, 5th ed. New York: Macmillan, 1975, pp. 1254–1307.
HuangXBrazelCS. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J Control Release2001; 73: 121–136.
70.
DuncanGJessTJMohamedF. The influence of protein solubilisation, conformation and size on the burst release from poly (lactide-co-glycolide) microspheres. J Control Release2005; 110: 34–48.
71.
ChenAZYangYMWangSB. Preparation of methotrexate-loaded, large, highly-porous PLLA microspheres by a high-voltage electrostatic antisolvent process. J Mater Sci Mater Med2013; 24: 1917–1925.
72.
WolinskyJBColsonYLGrinstaffMW. Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers. J Control Release2012; 159: 14–26.
73.
WuCZhuYChangJ. Bioactive inorganic-materials/alginate composite microspheres with controllable drug-delivery ability. J Biomed Mater Res B Appl Biomater2010; 94: 32–43.
74.
LiangY-HLiuC-HLiaoS-H. Cosynthesis of cargo-loaded hydroxyapatite/alginate core–shell nanoparticles (HAP@Alg) as pH-responsive nanovehicles by a pre-gel method. ACS Appl Mater Interfaces2012; 4: 6720–6727.
75.
DubnikaALocaDBerzina-CimdinaL. Functionalized hydroxyapatite scaffolds coated with sodium alginate and chitosan for controlled drug delivery. Proc Estonian Acad Sci2012; 61: 193–199.
76.
RubertMPullisaarHGómez-FloritM. Effect of TiO2 scaffolds coated with alginate hydrogel containing a proline-rich peptide on osteoblast growth and differentiation in vitro. J Biomed Mater Res A2013; 101: 1768–1777.
77.
PullisaarOHTiainenHLandinMA. Enhanced in vitro osteoblast differentiation on TiO2 scaffold coated with alginate hydrogel containing simvastatin. J Tissue Eng2013; 4: doi: 10.1177/2041731413515670– doi: 10.1177/2041731413515670.
78.
SiepmannFSiepmannJWaltherM. Polymer blends for controlled release coatings. J Control Release2008; 125: 1–15.
79.
BorgquistPKornerAPiculellL. A model for the drug release from a polymer matrix tablet-effects of swelling and dissolution. J Control Release2006; 113: 216–225.
